How much bacterial endotoxin is present? 118 batches of 83 products carry this result. Each one is listed below with its laboratory, method and result.
How much bacterial endotoxin is present? Endotoxins are fragments of the outer membrane of certain bacteria. They can remain after the bacteria themselves are gone, which is why they are measured separately from sterility. The LAL (Limulus amebocyte lysate) test described in USP <85> reports them in endotoxin units (EU) per mL or per vial, against the limit printed on the certificate.
Results as printed: "<0.05 EU/mL" on 52, "< 1 EU/vial" on 7, "<.25 EU/mL" on 5, "0.081 EU/mL" on 4, "0.061 EU/mL" on 4, "0.136 EU/mL" on 3, and 34 other readings.
Newest first. The batch number opens that batch's page with every test result and the original report.
| Tested | Product | Batch | Laboratory | Method | Result | Specification |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Capsulated KPV | KPV001 | ILS Laboratories | LAL | 0.071 EU/mL | Report only |
| Sep 8, 2026 | CJC-1295 No DAC & Ipamorelin | CJ01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Sep 4, 2026 | Adamax (DW 1032) | AD02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Sep 4, 2026 | Tesamorelin | TSM03 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Sep 4, 2026 | SS-31 | SS502 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Sep 1, 2026 | Cartalax | FX35 | ILS Laboratories | LAL | < 0.05 EU/mL | ≤ 5 EU/mL |
| Aug 29, 2026 | SS-31 & 5-Amino-1MQ | SAM01 | ILS Laboratories | LAL | 0.152 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | Transdermal BAM15 (25MG/ML) | BMTD01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | Transdermal SLU-PP-332 (10MG/ML) | SLTD01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | BAM15 | BAM01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | MT-1 Aerosol Kit | MT01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | Melanotan 1 | MT01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | MT-2 Aerosol Kit | MT02 | ILS Laboratories | LAL | 0.103 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | SLU-PP-332 100MG Capsules | 5513X | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | Melanotan 2 | MT02 | ILS Laboratories | LAL | 0.103 EU/mL | ≤ 5 EU/mL |
| Aug 24, 2026 | Bacteriostatic Water 0.9% | BAC02 | ILS Laboratories | USP <85> | 0.143 EU/mL | Report only |
| Aug 24, 2026 | Tesamorelin | TSM501 | ILS Laboratories | LAL | 0.073 EU/mL | ≤ 5 EU/mL |
| Aug 22, 2026 | L-Glutathione | GLU03 | ILS Laboratories | LAL | 0.143 EU/mL | ≤ 5 EU/mL |
| Aug 22, 2026 | KPV | KPV02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 22, 2026 | Wolverine (BPC-157 / TB-500) | BB02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 22, 2026 | BPC-157 | BPC02 | ILS Laboratories | LAL | .125 EU/mL | ≤ 5 EU/mL |
| Aug 17, 2026 | P21 (BDNF) | P201 | ILS Laboratories | LAL | 0.149 EU/mL | ≤ 5 EU/mL |
| Aug 17, 2026 | HeliosX (Clen & Yohimbine) | HX01 | ILS Laboratories | LAL | 0.051 EU/mL | ≤ 5 EU/mL |
| Aug 17, 2026 | HMG | HMG01 | ILS Laboratories | LAL | 0.104 EU/mL | ≤ 5 EU/mL |
| Aug 14, 2026 | VIP | VIP01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 14, 2026 | TB-500 (Thymosin Beta-4) | TB02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Sunifiram | SN01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Mirabegron (β₃ Adrenergic Agonist) | MB01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Albuterol (β₂ Adrenergic Agonist) | ALB | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Phenylpiracetam | PH01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Bromantane | BRO01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 6, 2026 | Minoxidil 5% / RU58841 5% (50ML) | RU01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 5, 2026 | HeliosX (Clen & Yohimbine) | HEL01 | ILS Laboratories | LAL | 0.127 EU/mL | ≤ 5 EU/mL |
| Aug 5, 2026 | Fasoracetam | FAS01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Aug 2, 2026 | ARA-290 | AA01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 31, 2026 | IGF1-LR3 | IGF02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 30, 2026 | AICAR | AR01 | ILS Laboratories | LAL | 0.072 EU/mL | ≤ 5 EU/mL |
| Jul 30, 2026 | DSIP | 5513X | ILS Laboratories | LAL | 0.183 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | Adalank (NA-Selank Amidate) | NAS01 | ILS Laboratories | LAL | <.25 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | Adalank Aerosol Spray | SNS01 | ILS Laboratories | LAL | <.25 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | High Dose 5-Amino-1MQ (50MG/ML) | 5AMX01 | ILS Laboratories | LAL | <.25 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | AOD-9604 | FX35 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | Thymosin Alpha-1 (Tα-1) | TA0404 | ILS Laboratories | LAL | 0.125 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | Tesamorelin | TSM03 | ILS Laboratories | LAL | 0.055 EU/mL | ≤ 5 EU/mL |
| Jul 26, 2026 | SS-31 | SSX01 | ILS Laboratories | LAL | <.25 EU/mL | ≤ 5 EU/mL |
| Jul 23, 2026 | BPC-157 | BC501 | ILS Laboratories | LAL | 0.202 EU/mL | ≤ 5 EU/mL |
| Jul 22, 2026 | Snap-8 | SNP01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 22, 2026 | Wolverine+ (Cartalax / BPC-157 / TB-500) | WLV+01 | ILS Laboratories | LAL | <.25 EU/mL | ≤ 5 EU/mL |
| Jul 22, 2026 | FOXO4-DRI | F001 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 17, 2026 | CJC-1295 No DAC | CND02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 17, 2026 | High Dose L-Glutathione (200MG/ML) | GLU03 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 17, 2026 | CJC-1295 Drug Affinity Complex | CWD02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 17, 2026 | Epitalon | EPI05 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 16, 2026 | KLOW (GHK-CU / BPC-157 / TB-500 / KPV) | K002 | ILS Laboratories | LAL | 0.173 EU/mL | ≤ 5 EU/mL |
| Jul 15, 2026 | Kisspeptin | KS02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 13, 2026 | Humanin (Mitochondrial Bioregulator) | HM01 | ILS Laboratories | LAL | 0.136 EU/mL | ≤ 5 EU/mL |
| Jul 10, 2026 | Pinealon Aerosol Spray | PNS01 | ILS Laboratories | LAL | 0.136 EU/mL | ≤ 5 EU/mL |
| Jul 9, 2026 | Eloralintide (Amylin Receptor Agonist) | EL01 | ILS Laboratories | LAL | 0.136 EU/mL | ≤ 5 EU/mL |
| Jul 8, 2026 | MT-2 Aerosol Kit | MT002 | Chromate | LAL | < 2 EU/vial | |
| Jul 8, 2026 | Melanotan 2 | MT002 | Chromate | LAL | < 2 EU/vial | |
| Jul 7, 2026 | Oxytocin Aerosol Kit | OX01 | ILS Laboratories | LAL | 0.082 EU/mL | ≤ 5 EU/mL |
| Jul 7, 2026 | Oxytocin | OX01 | ILS Laboratories | LAL | 0.082 EU/mL | ≤ 5 EU/mL |
| Jul 7, 2026 | Selank Aerosol Kit | SK01 | ILS Laboratories | LAL | 0.153 EU/mL | ≤ 5 EU/mL |
| Jul 7, 2026 | NAD+ (Nicotinamide Adenine Dinucleotide) | NAD005 | ILS Laboratories | LAL | 0.123 EU/mL | ≤ 5 EU/mL |
| Jul 7, 2026 | Selank | SK01 | ILS Laboratories | LAL | 0.153 EU/mL | ≤ 5 EU/mL |
| Jul 2, 2026 | Thymosin Alpha-1 (Tα-1) | TA0404 | ILS Laboratories | LAL | 0.081 EU/mL | ≤ 5 EU/mL |
| Jul 2, 2026 | Ipamorelin | IP01 | ILS Laboratories | LAL | 0.198 EU/mL | ≤ 5 EU/mL |
| Jul 2, 2026 | CJC-1295 No DAC & Ipamorelin | 335XA | ILS Laboratories | LAL | 0.12 EU/mL | ≤ 5 EU/mL |
| Jul 1, 2026 | NAD+ / MOTS-C / 5-Amino-1MQ Aerosol Spray | NM002 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 1, 2026 | 9-ME-BC (9-Methyl-β-carboline) | 5513X | ILS Laboratories | LAL | 0.081 EU/mL | ≤ 5 EU/mL |
| Jul 1, 2026 | Tesamorelin & Ipamorelin | TI05 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 1, 2026 | MitoPrime (NAD+ / MOTs-C / 5-Amino-1MQ) | NM002 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jul 1, 2026 | L-Carnitine (600MG/ML) | 060526 | ILS Laboratories | LAL | 0.081 EU/mL | ≤ 5 EU/mL |
| Jun 27, 2026 | Adamax Aerosol Spray (DW 1032) | ADN01 | ILS Laboratories | LAL | 0.057 EU/mL | ≤ 5 EU/mL |
| Jun 27, 2026 | Adamax (DW 1032) | AD05 | ILS Laboratories | LAL | 0.057 EU/mL | ≤ 5 EU/mL |
| Jun 27, 2026 | Melanotan 2 | MT002 | Chromate | LAL | < 2 EU/vial | < 80 EU/vial |
| Jun 24, 2026 | Amino Tadalafil | 060526 | ILS Laboratories | LAL | 0.081 EU/mL | ≤ 5 EU/mL |
| Jun 24, 2026 | MOTs-C | 4394A | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 23, 2026 | Acetic Acid 0.6% | 5159981X | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 23, 2026 | 5-Amino-1MQ | 5AM01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 19, 2026 | Capsulated BPC-157 Arginate Salt | 0X0568 | ILS Laboratories | LAL | 1.939 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | NAD+ Pen 1000MG | NADPEN01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GLOW (GHK-Cu 50MG / BPC-157 10MG / TB-500 10MG ) Pen | GLOWPEN01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GHK-Cu Pen 100MG | GHKCUPEN01 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | AHK-Cu | AHK005 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Kisspeptin | KP02 | ILS Laboratories | LAL | 0.053 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Semax Aerosol Kit | SX01 | ILS Laboratories | LAL | 0.075 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GLOW (GHK-CU / BPC-157 / TB-500) | GLO02 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GLOW (GHK-CU / BPC-157 / TB-500) | GL03 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | L-Glutathione | Ox5368 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | KPV | 5159981X | ILS Laboratories | LAL | 2.585 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Wolverine (BPC-157 / TB-500) | BB03 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | NAD+ (Nicotinamide Adenine Dinucleotide) | NAD002 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Semax | SX01 | ILS Laboratories | LAL | 0.075 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Bacteriostatic Water 0.9% | FX35 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | Bacteriostatic Water 0.9% | BA001 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GHK-Cu | CU004 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 10, 2026 | GHK-Cu | CU501 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 9, 2026 | MOTs-C | MS03 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| Jun 8, 2026 | PT-141 Aerosol Kit | 5159981X | ILS Laboratories | LAL | 0.061 EU/mL | ≤ 5 EU/mL |
| Jun 8, 2026 | PT-141 | 5159981X | ILS Laboratories | LAL | 0.061 EU/mL | ≤ 5 EU/mL |
| Jun 6, 2026 | SS-31 Aerosol Spray | 5159981X | ILS Laboratories | LAL | 0.061 EU/mL | ≤ 5 EU/mL |
| Jun 6, 2026 | SS-31 | 59981X | ILS Laboratories | LAL | 0.061 EU/mL | ≤ 5 EU/mL |
| Jun 3, 2026 | HGH FRAG 176-191 | FRAG001 | ILS Laboratories | LAL | <0.05 EU/mL | ≤ 5 EU/mL |
| May 31, 2026 | DSIP Aerosol Kit | 5513X | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 31, 2026 | DSIP | 5513X | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 17, 2026 | MT-1 Aerosol Kit | U3X35 | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 17, 2026 | Melanotan 1 | U3X35 | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 17, 2026 | IGF1-LR3 | 55F | Chromate | LAL | < 0.5 EU/vial | < 80 EU/vial |
| May 17, 2026 | CJC-1295 No DAC & Ipamorelin | #35025 | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 17, 2026 | MOTs-C | 335XA | Chromate | LAL | < 2.5 EU/vial | < 80 EU/vial |
| May 17, 2026 | MOTs-C | 4349A | Chromate | LAL | 1.14 EU/vial | < 80 EU/vial |
| May 12, 2026 | 5-Amino-1MQ | #35352 | Chromate | LAL | < 1 EU/vial | < 80 EU/vial |
| May 8, 2026 | GHK-Cu | 5613X | Chromate | LAL | < 5 EU/vial | < 80 EU/vial |
| May 8, 2026 | GHK-Cu | #35747 | Chromate | LAL | < 5 EU/vial | < 80 EU/vial |
| Apr 22, 2026 | GLOW (GHK-CU / BPC-157 / TB-500) | FEB29 | Chromate | LAL | < 4.5 EU/vial | < 80 EU/vial |
| Apr 22, 2026 | Wolverine (BPC-157 / TB-500) | 543D | Chromate | LAL | < 1 EU/vial | |
| Mar 24, 2026 | Bacteriostatic Water 0.9% | 5159981X | Chromate | LAL | < 0.25 EU/mL |
The other tests: Identity · Purity · Net content · Sterility · Heavy metals · Fentanyl screen. Or go back to all eight tests.